Daxor (NASDAQ:DXR – Get Free Report) and Addus HomeCare (NASDAQ:ADUS – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, institutional ownership and earnings.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Daxor and Addus HomeCare, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Daxor | 0 | 1 | 2 | 0 | 2.67 |
| Addus HomeCare | 1 | 2 | 6 | 1 | 2.70 |
Daxor presently has a consensus price target of $25.00, indicating a potential upside of 108.33%. Addus HomeCare has a consensus price target of $134.89, indicating a potential upside of 28.22%. Given Daxor’s higher possible upside, research analysts clearly believe Daxor is more favorable than Addus HomeCare.
Volatility and Risk
Insider & Institutional Ownership
1.3% of Daxor shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 59.5% of Daxor shares are owned by company insiders. Comparatively, 4.5% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings & Valuation
This table compares Daxor and Addus HomeCare”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Daxor | $3.31 million | 18.26 | N/A | N/A | N/A |
| Addus HomeCare | $1.42 billion | 1.37 | $73.60 million | $4.67 | 22.53 |
Addus HomeCare has higher revenue and earnings than Daxor.
Profitability
This table compares Daxor and Addus HomeCare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Daxor | N/A | N/A | N/A |
| Addus HomeCare | 6.74% | 9.99% | 7.23% |
Summary
Addus HomeCare beats Daxor on 9 of the 12 factors compared between the two stocks.
About Daxor
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Receive News & Ratings for Daxor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daxor and related companies with MarketBeat.com's FREE daily email newsletter.
